LeonaBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
LeonaBio, Inc. (LONA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $15.27 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $15.27.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $35.87.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $37.44.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $37.37.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2026-06-30 | $15.27 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $35.87 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $37.44 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $37.37 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $5.13 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $5.52 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $60.83 10-K · filed 2026-03-31 | $6.08 10-K · filed 2025-02-27 |
| 2024-09-30 | $6.18 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $6.14 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $6.39 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $7.97 10-K · filed 2025-02-27 | |
| 2023-09-30 | $7.88 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $7.90 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $8.56 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $11.75 10-K · filed 2024-02-22 | |
| 2022-09-30 | $11.93 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $12.28 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $12.44 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $12.76 10-K · filed 2023-03-23 | |
| 2021-09-30 | $13.39 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $12.87 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $12.32 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $9.31 10-K · filed 2022-03-28 | |
| 2020-09-30 | $8.85 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $1.03 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |